| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	
 
																	
 
																	
 
																	Keybanc analyst Justin Patterson initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Sector Weight rating.
 
																	Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our t...
 
																	Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.
 
																	Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he ...
 
																	Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-lo...
 
																	https://www.youtube.com/watch?v=xagrobF4q1k